Lab100 opened in the fall of 2018 at Mount Sinai’s Upper East Side location. The hybrid lab uses advanced diagnostic screening tools, digital applications and data science to create a comprehensive health report enabling patients to be proactive in managing their own health. It also provides researchers and innovators with health data to inform the development of preventive treatments.
Under the new partnership, Onegevity will manage Lab100’s global licensing, expanding the lab’s model of personalized, preventive care to other communities, ultimately resulting in innovative advancements in data-driven care delivery across the U.S., according to Joel Dudley, PhD, director of Mount Sinai’s Institute for Next Generation Healthcare and co-founder of Onegevity.
More articles on innovation:
CHLA Innovation Studio announces winners of health tech accelerator
NIH awards $1.7M to grow health tech research and development network
Partners pours $80M into investment funds for digital tech, AI, life sciences
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
